Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rapid test could help fight superbugs in veterans

NCT ID NCT02060513

Diagnosis Sponsor: Connie Price Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested a new rapid diagnostic tool to quickly identify antibiotic-resistant bacteria in wounded warriors and veterans. Over 2,200 participants provided samples from blood, lungs, or skin. The goal was to see if the test could accurately detect resistant bacteria faster than standard lab methods, helping doctors choose the right antibiotic sooner.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this rapid test could help doctors choose the right antibiotic faster, reducing ineffective treatments and slowing antibiotic resistance.
What could go wrong
This is a diagnostic study, not a treatment trial. The test's accuracy may not be high enough in real-world settings, and it does not directly improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

2,298 people

The number who actually took part.

Start date

Aug 2013

Finished

Nov 2016

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Inpatients with a suspected infection.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years old. * Microbiology culture (respiratory, blood or tissue/skin) ordered during regular clinical care. Exclusion Criteria: * Insufficient sample volume available after clinical test completed.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthcare associated infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Infections infectious disease nosocomial infection skin disease caused by bacterial infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthcare associated infection Infection Infection due to resistant bacteria Skin and subcutaneous tissue bacterial infections

Contacts and locations

Locations

  • Denver Health Medical Center

    Denver, Colorado, 80204, United States

  • Denver Veterans Affairs Eastern Colorado Health Care System

    Denver, Colorado, 80220, United States

  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.